BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30360988)

  • 1. Clinical outcome after resection of early-stage hilar cholangiocarcinoma.
    Stremitzer S; Jones RP; Quinn LM; Fenwick SW; Diaz-Nieto R; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2019 Feb; 45(2):213-217. PubMed ID: 30360988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery for hilar cholangiocarcinoma: the Leeds experience.
    Hidalgo E; Asthana S; Nishio H; Wyatt J; Toogood GJ; Prasad KR; Lodge JP
    Eur J Surg Oncol; 2008 Jul; 34(7):787-94. PubMed ID: 18036765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic procedures and results in surgical therapy for cholangiocarcinoma].
    Schüle S; Altendorf-Hofmann AK; Knösel T; Uteß F; Settmacher U
    Zentralbl Chir; 2014 Dec; 139 Suppl 2():e25-34. PubMed ID: 22274918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
    Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
    Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma.
    Uchiyama K; Nakai T; Tani M; Onishi H; Kinoshita H; Kawai M; Ueno M; Yamaue H
    Arch Surg; 2003 Sep; 138(9):1012-6. PubMed ID: 12963661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
    Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
    Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
    Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
    Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.
    Song SC; Choi DW; Kow AW; Choi SH; Heo JS; Kim WS; Kim MJ
    ANZ J Surg; 2013 Apr; 83(4):268-74. PubMed ID: 22943422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
    Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
    Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive surgical resection for cholangiocarcinoma.
    Washburn WK; Lewis WD; Jenkins RL
    Arch Surg; 1995 Mar; 130(3):270-6. PubMed ID: 7534059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for hilar cholangiocarcinoma: feasibility and results of parenchyma-conserving liver resection.
    Ramesh H; Kuruvilla K; Venugopal A; Lekha V; Jacob G
    Dig Surg; 2004; 21(2):114-22. PubMed ID: 15024176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III.
    Grandadam S; Compagnon P; Arnaud A; Olivié D; Malledant Y; Meunier B; Launois B; Boudjema K
    Ann Surg Oncol; 2010 Dec; 17(12):3155-61. PubMed ID: 20593243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single centre experience with surgical treatment of hilar cholangiocarcinoma.
    Vladov N; Lukanova Ts; Takorov I; Mutafchiyski V; Vasilevski I; Sergeev S; Odisseeva E
    Chirurgia (Bucur); 2013; 108(3):299-303. PubMed ID: 23790776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?
    Nguyen KT; Steel J; Vanounou T; Tsung A; Marsh JW; Geller DA; Gamblin TC
    Ann Surg Oncol; 2009 Dec; 16(12):3308-15. PubMed ID: 19774418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution.
    Xiao J; Zhu J; Liu Z; Wan R; Li Y; Xiao W
    J Cancer Res Ther; 2017; 13(5):756-760. PubMed ID: 29237899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution.
    Kow AW; Wook CD; Song SC; Kim WS; Kim MJ; Park HJ; Heo JS; Choi SH
    World J Surg; 2012 May; 36(5):1112-1121. PubMed ID: 22374541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.